# Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study

> **NCT00911521** · PHASE4 · COMPLETED · sponsor: **Tuen Mun Hospital** · enrollment: 100 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** human papillomavirus vaccination (Gardasil)

## Key facts

- **NCT ID:** NCT00911521
- **Lead sponsor:** Tuen Mun Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-03
- **Final completion:** 2011-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2011-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00911521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00911521, "Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00911521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*